Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransferases.
about
How are abnormal results for liver function tests dealt with in primary care? Audit of yield and impactAcute and Subchronic Toxicity Study of the Median Septum of Juglans regia in Wistar RatsNormal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort studyShould patients with abnormal liver function tests in primary care be tested for chronic viral hepatitis: cost minimisation analysis based on a comprehensively tested cohort.Abnormal findings on liver function tests. Interpreting results to narrow the diagnosis and establish a prognosis.An in vitro and in vivo study of the α-amylase activity of phaseolaminAssociated liver enzymes with hyperlipidemic profile in type 2 diabetes patients.Steatosis and steatohepatitis in postmortem material from Northwestern GreeceLiver disease in ulcerative colitis: an epidemiological and follow up study in the county of Stockholm.Non-alcoholic fatty liver disease: an overview.Non-alcoholic fatty liver: a common manifestation of a metabolic disorder.Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition.Best practice in primary care pathology: review 5.Probability of C282Y homozygosity decreases as liver transaminase activities increase in participants with hyperferritinemia in the hemochromatosis and iron overload screening study.Clinical review of nonalcoholic steatohepatitis in liver surgery and transplantationLiver disease in general practice.Low yield of unselected testing in patients with acutely abnormal liver function testsA Comparison of Uremic Pruritus in Patients Receiving Peritoneal Dialysis and HemodialysisAbnormal liver enzyme levels. Evaluation in asymptomatic patients.Antidiabetic effects of dendropanoxide from leaves of Dendropanax morbifera Leveille in normal and streptozotocin-induced diabetic rats.Role of the standard 'liver function tests' in current clinical practice.SAF score and mortality in NAFLD after up to 41 years of follow-up.Hepatobiliary changes in patients with ulcerative colitis, with special reference to the effect of proctocolectomy.A randomized controlled open study of interferon alpha-2b treatment of chronic non-A, non-B posttransfusion hepatitis: no correlation of outcome to presence of hepatitis C virus antibodies.Biochemical "liver function tests".Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up.Upper limit of normal serum alanine aminotransferase levels in Japanese subjects.Phytochemical characterization of the Vochysia rufa (Vochysiaceae) extract and its effects on oxidative stress in the pancreata of streptozotocin-induced diabetic rats.Relationship between body mass index and alanine aminotransferase concentration in non-diabetic Korean adults.Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study.Managing chronic hepatitis. Recent advances in diagnosis and treatment.High prevalence of metabolic complications in patients with non-alcoholic fatty liver disease.The hypoglycemic and antioxidant activities of garden cress (Lepidium sativum L.) seed on alloxan-induced diabetic male rats.Elevated Liver Enzymes in Asymptomatic Patients - What Should I Do?Guidelines on the management of abnormal liver blood tests.
P2860
Q28346016-EEB0D2B5-4DC1-4619-89B4-CCC3A25BFCEBQ28468554-4CB12F1A-3344-488F-B1BF-E3FA5AA13009Q33709267-A9F4101F-593A-4172-8386-82412A6F44F8Q33836312-E5911940-5B0B-48B5-8B85-F4E0C625A882Q33846635-29B4CCB7-5243-4EC8-929D-46F0F8159AE2Q34019332-0CCA3C41-699C-48E0-BC67-F808FE714B76Q34029281-350F6BE9-1B6E-46F5-AB73-6F5AC1AF52B4Q34073625-56A787CC-43F1-48E4-89E9-D669A50624A5Q34378444-AB73F183-4EDB-4F32-AA09-91BD899FEB6FQ35009628-6F8F9162-D55B-4B8A-93BB-BF19F7E9729DQ35538766-075C2A41-C9FE-40EC-A4BD-FCBACBB4AD3DQ35562084-5A4E2632-7055-4442-9FF8-E1CFFA787415Q35770421-2E51C9E5-3FE7-4ED6-A48A-BEFF9EF0BAB2Q35968720-2C7E086C-9A62-4E62-85E9-FCF901330E87Q36165357-7DA95309-C39B-4E10-B19F-E9A7CC355832Q36415226-13B53DA0-ACE7-4B66-A45B-BECA25E265ACQ36455025-084684E3-F4A9-4FEA-B8C6-3AD8611345BEQ36664020-9A3026AB-3E1D-42D3-B882-A42653C908CAQ37651396-253DCD43-B320-4A30-B078-2B46E1820FEBQ38482562-F954A313-02B5-43CB-A41A-087BEC1B280BQ38763271-A3BE7E0F-C45A-4C76-A904-53E3F22EC05EQ39402697-4D38790D-CB44-457E-AF15-39DF1AE9F0BBQ41727893-CC4D5DB7-B080-4208-8B8E-6BD3D8A5D359Q41785495-7959ECA8-9166-4CBE-8112-05BC3CCE4D5BQ42008710-F3C35823-B0DF-4D18-B8B5-612F8F724742Q42201783-C01D4D73-4565-4FB1-84C0-162DE059479EQ42246516-84D432C6-A995-4E85-A2A0-069577F84DB1Q42370675-76B661E3-2E19-4524-AD79-4A31AECF9D29Q43244690-DB46F549-1146-4C57-8A17-C1552756DD7CQ43742730-BE2243A3-E372-4A2D-BE47-B74D1849DEB3Q43919722-69793459-6D0D-4692-83B9-94146627BD69Q45129535-FE60DD39-8CEB-44B5-A6AF-E459476C660BQ46343609-CBE713AC-0B2C-4B8B-A1E3-555F0ED401D9Q47156253-9DC9927D-97AF-49BA-9DD7-7AB1F8678F65Q47613489-150E667B-68C8-4753-BAFA-95AC2FD22B95
P2860
Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransferases.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh-hant
name
Liver investigation in 149 asy ...... es of serum aminotransferases.
@en
Liver investigation in 149 asy ...... es of serum aminotransferases.
@nl
type
label
Liver investigation in 149 asy ...... es of serum aminotransferases.
@en
Liver investigation in 149 asy ...... es of serum aminotransferases.
@nl
prefLabel
Liver investigation in 149 asy ...... es of serum aminotransferases.
@en
Liver investigation in 149 asy ...... es of serum aminotransferases.
@nl
P2093
P2860
P1476
Liver investigation in 149 asy ...... es of serum aminotransferases.
@en
P2093
Glaumann H
Hultcrantz R
Lindberg G
Nilsson LH
P2860
P304
P356
10.3109/00365528609034632
P577
1986-01-01T00:00:00Z